Rockville, MD – Aug. 27, 2014 / PR Newswire / -Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics,and Nutraceuticals, held a ribbon-cutting ceremony on September 3, 2014, in Tasly’s corporate offices in Rockville, MD. The ceremony marked the official launch of Tasly Pharmaceuticals, Inc. as the North American headquarters of Tasly Holding Group, a global technology company established in China that in May 2014 proudly celebrated its 20th anniversary.
The ceremony included over 150 distinguished guests and dignitaries, including Tasly’s corporate leaders, Maryland state officials, high-level media representatives, business development executives, as well as officials from Maryland’s biotechnology and pharmaceutical communities.
Tasly is pioneering the most aggressive paradigm shift in modern medicine: scientifically proving that the 5,000-year old medical practice of Modern Traditional Chinese Medicine (mTCM) – healing the body with pure, natural herbs, is as effective as treating it with chemical and synthetic drug compounds. This will fulfill an unmet clinical need for healthcare providers and patients alike by being able to treat serious diseases with chemical-free products, which could be a game changer in modern medicine.
Tasly, whose pharmaceutical products have been approved by national health regulatory authorities in no less than 34 countries worldwide, is currently undergoing the U.S. FDA Phase III Clinical Trials for its cardio-tonic pill, intended for treatment of stable angina pectoris. The revolutionary pill is expected to be the first-ever multi herb-based and chemical-free pharmaceutical product approved by the FDA.
For more information about Tasly Pharmaceuticals, Inc. and Deepure, please visit www.taslyus.com.